What is the recommended treatment and dosage for sucralfate (sucralfate) in treating stomach and duodenal ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sucralfate Treatment for Stomach and Duodenal Ulcers

For treatment of duodenal ulcers, sucralfate should be administered at a dose of 1 g four times per day on an empty stomach for 4-8 weeks, while gastric ulcers may require the same dosing regimen but with potentially lower healing rates. 1

Recommended Dosage Regimens

Active Ulcer Treatment

  • For active duodenal ulcers, the FDA-approved dosage is 1 g four times daily on an empty stomach, continuing for 4-8 weeks unless healing has been demonstrated by x-ray or endoscopic examination 1
  • Antacids may be prescribed for pain relief but should not be taken within 30 minutes before or after sucralfate 1
  • Sucralfate works by binding to proteinaceous material at the ulcer site, forming a protective barrier against acid, pepsin, and bile salts 2
  • Healing may begin during the first 1-2 weeks of treatment, but the full 4-8 week course is recommended to ensure complete healing 1

Maintenance Therapy

  • For maintenance therapy after ulcer healing, the recommended dosage is 1 g twice daily 1
  • Maintenance therapy with sucralfate 1 g twice daily has been shown to reduce duodenal ulcer relapse rates from approximately 60% to 20% after 6 months, and from 81% to about 30% after one year 3

Clinical Efficacy and Positioning

  • Proton pump inhibitors (PPIs) are generally considered first-line agents for treating and preventing gastrointestinal ulcers, with sucralfate recommended as a second-line agent 4, 5
  • For H. pylori-associated ulcers, eradication therapy should be used in addition to sucralfate 4, 6
  • In comparative studies, sucralfate 1 g four times daily has shown healing rates comparable to cimetidine and ranitidine for duodenal ulcers (75-97.6% after 4-8 weeks) 7
  • Gastric ulcer healing rates with sucralfate tend to be lower than for duodenal ulcers, but are still comparable to those achieved with H2-receptor antagonists 8

Special Patient Populations

  • In elderly patients, dose selection should be cautious, usually starting at the lower end of the dosing range, due to potential decreased hepatic, renal, or cardiac function 1
  • For critically ill patients requiring stress ulcer prophylaxis, PPIs or H2-receptor antagonists are typically preferred over sucralfate 4, 5
  • For NSAID-induced ulcers, discontinuation of NSAIDs is recommended when possible; if NSAIDs must be continued, PPIs are preferred for gastroprotection 4, 6

Safety Profile and Administration Considerations

  • Sucralfate has minimal systemic absorption (3-5%), with more than 90% excreted unchanged in feces, resulting in few systemic side effects 2
  • The most common side effect is constipation (2-4%), with xerostomia (1%) and skin eruptions (0.6%) reported less frequently 2, 8
  • Sucralfate should be taken on an empty stomach, typically 1 hour before meals and at bedtime 1, 2
  • No significant drug-drug interactions have been reported, but sucralfate should not be taken within 30 minutes of antacids 1, 2

Alternative Dosing Regimens

  • Some studies suggest that 2 g twice daily may be as effective as the conventional 1 g four times daily regimen for duodenal ulcer healing 3
  • For maintenance therapy to prevent gastric ulcer relapse, a regimen of 1 g in the morning and 2 g at night has shown efficacy 3
  • Recent evidence suggests that a single nocturnal dose of 2 g may offer effective maintenance therapy for both duodenal and gastric ulcers 3

References

Research

The efficacy, safety and dosage of sucralfate in ulcer therapy.

Scandinavian journal of gastroenterology. Supplement, 1987

Guideline

Sucralfate Treatment for Stomach and Duodenal Ulcers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gastrointestinal Ulcer and Acid Reflux Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Duodenal Ulcer Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.